Androgen Use Among Female Amateur Athletes: A Retrospective Analysis
Scandinavian Journal of Medicine & Science in Sports · 2026
DOI: 10.1111/sms.70207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Medicine & Science in Sports, 2026. Verfasst von Tijs Johannes Verdegaal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Spaarne Gasthuis, Boerhaavelaan, Haarlem, the Netherlands. Hauptthemen laut MEDLINE: Androgens, Athletes, Performance-Enhancing Substances. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Dutch Anti-Doping Authority.
Abstract (Originalsprache)
Most research on non‐prescribed androgen use has focused on men, while women remain underrepresented in the literature, despite unique risks such as virilization and reproductive consequences. This is one of the largest described cohorts of females who use androgen, all of whom underwent in‐person consultation, allowing for a more reliable characterization compared to previous studies. We conducted a retrospective chart review of all female patients with a history of non‐prescribed androgen use attending a harm reduction clinic in the Netherlands between April 2023 and August 2025. Demographics, training background, motivations, patterns of androgen, and other performance‐ and image‐enhancing drug (PIED) use were extracted. Descriptive statistics were applied. Forty‐one women were included (median age 33 years, range 22–59). All performed weekly resistance training, and most (75%) were competitive amateur bodybuilders. The primary motivation was improvement of body composition, muscle size, and strength. Most reported intermittent oral cycles with oxandrolone. Continuous use beyond 1 year was rare. The most frequently used androgen was oxandrolone (88%). Clenbuterol, thyroid hormone, and growth hormone were the most frequent non‐androgen PIEDs. Androgen use in this outpatient female cohort was characterized by lower dosages than commonly reported in male cohorts, predominantly oral administration, and motivations tied almost exclusively to bodybuilding or strength sports. While these patterns may reduce some dose‐dependent risks such as heart failure, reliance on oral androgens increases the risk of hepatotoxicity and adverse lipid effects. A prospective study with a systematic approach is required to provide more reliable data on the health risk of androgen use in women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Spaarne Gasthuis, Boerhaavelaan, Haarlem, the Netherlands.
- Department of Endocrinology and Metabolism, Amsterdam UMC, Amsterdam, the Netherlands.
- Department of Performance and Image-Enhancing Drugs Research, Android Health Clinic, Utrecht, the Netherlands.
- Department of Internal Medicine, Zaandam Medical Centre, Zaandam, the Netherlands.
ORCID-Profile: Tijs Johannes Verdegaal
Förderung
- Dutch Anti-Doping Authority
Zitieren
APA
Verdegaal, T. J., Jansen, M., Bond, P., de Ronde, W., & Smit, D. L. (2026). Androgen Use Among Female Amateur Athletes: A Retrospective Analysis. Scandinavian Journal of Medicine & Science in Sports. https://doi.org/10.1111/sms.70207
Vancouver
Verdegaal TJ, Jansen M, Bond P, de Ronde W, Smit DL. Androgen Use Among Female Amateur Athletes: A Retrospective Analysis. Scandinavian Journal of Medicine & Science in Sports. 2026. doi:10.1111/sms.70207
BibTeX
@article{Verdegaal2026,
author = {Verdegaal, Tijs Johannes and Jansen, Manon and Bond, Peter and de Ronde, Willem and Smit, Diederik Laurens},
title = {Androgen Use Among Female Amateur Athletes: A Retrospective Analysis},
journal = {Scandinavian Journal of Medicine & Science in Sports},
year = {2026},
doi = {10.1111/sms.70207}
}
EUVIMED